Document:

exv10w43

 

Exhibit 10.43

EMPLOYMENT AGREEMENT

     THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of August 2, 2004, by and
between ATHENAHEALTH, INC. (the “Company”), and Nancy G. Brown (“Employee”).

     The parties hereby agree as follows:

     1. Employment; Term.

          (a) The Company employs Employee, and Employee accepts employment with the Company, upon the
terms and conditions contained in this Agreement.

          (b) Term of Employment. The Company and Employee acknowledge that Employee’s
employment is at-will, and is for no definite period of time. Employee acknowledges and agrees that
this Agreement will govern the terms of Employee’s employment with Company, even though
compensation levels may be adjusted by Company from time to time by assent of the parties hereto.

     2. Duties.

     During the Employment Period, Employee shall serve as Senior Vice President, Clinical Cycle
Development or in such other positions and with such other duties and responsibilities as Company
shall from time to time assign to employee. Employee shall perform faithfully for the Company the
duties of Employee’s position and in accordance with the reasonable directives of the Company.
Employee shall comply with procedures and policies as established by the Company from time to time.
Employee shall devote substantially all of Employee’s business time and effort to the performance
of Employee’s duties to the Company. Employee acknowledges that execution of Employee’s duties in
a timely, consistent and prudent manner is vital to the successful operations of the Company and
that it is essential that Employee conduct the duties of this position with constant and watchful
attention.

     3. Compensation

          (a) Employee’s base salary will be at an annual gross rate of $150,000 (the “Base Salary”).
The Base Salary shall be payable in accordance with the Company’s payroll practices, as in effect
from time to time, and shall be subject to required federal, state and local taxes and
withholdings. In addition, Employee will be entitled to a signing bonus of $15,000, payable after
both start of employment and relocation to Boston are fulfilled. The signing

 

 

bonus is not based on Employee’s performance and will be paid in a timely fashion. Employee
will be entitled to annual consideration for a bonus of up to 18.5% of base, based on Employee’s
and the Company’s performance. Such bonus, if any, shall be determined by the Company in its sole
discretion, and shall be paid as and according to the schedule that other bonus payments are
generally made by the Company to its employees.

          (b) In the event the Employee’s employment with the Company is terminated by Employee for Good
Reason (as defined below) or by the Company without Cause (as defined below), the Company shall
within ten business days after the effective date of termination pay to Employee severance in such
amount as is proportionally (measured by severance amount against base salary) equal to the average
rate of cash severance, if any, that has been paid by the Company to management level employees who
are at or above Employee’s level of responsibility in the Company and whose employment was
terminated at any time during the two years prior to Employee’s termination not as a result of
settlement of legal claims and not in situations where “cause” (as defined in this Agreement or as
defined in the employment agreement related to the particular employee, if different) existed or
was alleged at the time by Company to exist.

          (c) For purposes of Section (a) above, the following shall constitute “Cause” for such
termination: (i) willful and material dishonest statements or reports of the Employee to the
Company or any affiliate of the Company or willful and material dishonest acts of the Employee with
respect to the Company or any affiliate of the Company; (ii) the commission by or indictment of the
Employee for (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or
fraud (“indictment,” for these purposes, meaning an indictment, probable cause hearing or any other
procedure pursuant to which an initial determination of probable or reasonable cause with respect
to such offense is made); (iii) engaging in dishonest, unethical, or untruthful behavior or
statements in the reasonable belief of the Company’s President or material breach by the Employee
of any of the Employee’s obligations under this Agreement; (iv) disloyalty, willful misconduct,
willful insubordination, fraud or breach of fiduciary duty to the Company (v) willful violation of
the rules or policies of the Company or willful breach of Employee’s obligations or representations
under this Agreement; (vi) the unauthorized disclosure of any Company trade secret or other
confidential information of the Company; or (vii) death or mental or physicial disability or
infirmity.. Nothing in the foregoing will waive or modify any obligation of the Company to comply
with any law or regulation including but not limited to any anti-discrimination law or regulation.
Cause shall be deemed to exist under clauses (iii), (v) and (vi) of this paragraph only if the
events or behavior alleged to constitute “Cause” continue, in the reasonable judgment of the Chief
Development Officer, President or Chief Executive Officer of the Company, for a period of not less

-2-

 

than 30 days after the Company has given written notice to the Employee of
such events or behavior, or if Employee has not, within such 30-day period, substantially
cured the effects of such events or behavior, provided that if material and irreparable injury is
likely to result to the Company by reason of the passage of all or any portion of such 30- day
period, then the period shall be deemed waived.

     For purposes of Section (a) above, the following events shall constitute “Good Reason”: (i)
any significant diminution, without Employee’s prior written consent, in the nature or scope of
Employee’s responsibilities, authorities, powers, functions or duties not for Cause as set forth
above unless Employee is offered another senior management position in the Company no less senior
than her position as it existed prior to any such diminution or (ii) a material breach by the
Company of any of the Company’s obligations under this Agreement, provided that in the event of
termination for Good Reason, Employee shall first comply with the “Good Reason Process.” “Good
Reason Process” shall mean that (i) the Employee reasonably determines in good faith that a “Good
Reason” event has occurred; (ii) Employee notifies the Company in writing of the occurrence of the
Good Reason event; (iii) Employee cooperates in good faith with the Company’s efforts, for a period
not less than 30 days following such notice, to modify Employee’s employment situation in a manner
so as to cure any Good Reason without creating further Good Reason; and (iv) notwithstanding such
efforts, the Good Reason continues to exist. If the Company cures the Good Reason event during the
30-day period referenced in this Section 6(b), Good Reason shall be deemed not to have occurred.
For a termination to be for Good Reason, Employee must terminate within 30 days of the date that
Employee is entitled to terminate for Good Reason hereunder. Notwithstanding the foregoing,
temporary diminution of Employee’s responsibilities, authorities, powers, functions or duties
pending investigation or determination of Cause or pending inquiry into the grounds for or
circumstances of any allegation, investigation or proceeding initiated by any governmental
authority or agency regarding Employee or involving Employee’s actions for the Company shall not be
deemed Good Reason or a Good Reason event.

     4. Stock Option Grant,

     Following the execution of this Agreement, the Company shall grant Employee a non-qualified
option to purchase 190,000 shares of the Company’s Common Stock. The option grant shall be
contingent upon approval of the Board of Directors and subject to the terms and conditions in the
Company’s stock option plan and in the Company’s stock option agreement forms, vesting over a
period of four years.

-3-

 

     5. Expenses; Benefits.

          (a) The Company agrees to reimburse Employee, in accordance with the Company’s policies, for
reasonable expenses paid or incurred by Employee in connection with the performance of Employee’s
duties for the Company hereunder. Employee will be eligible for expense reimbursement of up to
$30,000 for the cost of relocation to Boston and trips to Boston associated with the move; however,
more than one moving bid must be obtained and reimbursement is contingent upon submittal of
receipts

          (b) Employee shall be entitled to 17 days of vacation annually, which vacation shall accrue at
a rate of 1.4 days per month. The vacation year begins on Employee’s anniversary date. Of the
vacation days not taken at the end of the vacation year, only ten days may be carried forward to
the following year. Employee may not receive cash in lieu of the days not taken, except with
written consent of the HR Committee.

          (c) Employee shall be entitled to participate in health, life, or disability insurance, and
retirement, pension, or profit-sharing plans that may be instituted by the Company for the benefit
of its mid-level management Employees generally, upon such terms contained therein.

     6. Termination.

          (a) Since Employee’s employment is at-will employment, either Employee or the Company may
terminate Employee’s employment at any time for any reason or for no reason.

          (b) Upon the termination of Employee’s employment for any reason, the parties shall have no
further obligations, except that those obligations of Employee under Sections 7, 8, 9 and 10, and
the provisions of Sections 12 and 13 shall remain in effect and binding upon the parties.

     7. Effect of Termination.

          (a) The Company shall have no liability or obligation to Employee upon Employee’s termination
other than as specifically set forth in this Section 7, or as provided by law.

          (b) Upon the termination of Employee’s employment, Employee shall be entitled to receive only
such portion (if any) of the Base Salary as may have accrued but be unpaid on the date of
termination, plus severance as provided in Section 3, above, any accrued and unpaid vacation pay,
outstanding expenses reimbursable under the Company’s then-applicable policies and other benefits
which may be owing through the date of termination.

-4-

 

          (c) Upon the termination of Employee’s employment for any reason, Employee shall immediately
surrender to the Company all Company property in the possession, custody or control of Employee,
including but not limited to any computer hardware, software, computer disks and/or data storage
devices, notes, data, sketches, drawings, manuals, documents, records, data bases, programs,
blueprints, memoranda, specifications, customer lists, financial reports, equipment and all other
physical forms of expression incorporating or containing any Confidential Information (as defined
in Section 8 hereof), it being distinctly understood that all such writings, physical forms of
expression and other things are exclusive property of the Company.

     8. Confidential Information and Inventions.

          (a) Employee recognizes and acknowledges that during the course of Employee’s employment with
the Company, Employee shall have access to Confidential Information. “Confidential Information”
means all information or material not publicly know which relates to any of its products, services
or any phase of its operations, business or financial affairs. Confidential Information includes,
but is not limited to, the following types of information and other information of a similar nature
(whether or not reduced to writing): trade secrets, inventions, drawings, file data, documentation,
diagrams, specifications, know-how, processes, formulas, models, flow charts, software completed or
in various stages of development, source codes, object codes, research and development procedures,
test results, marketing techniques and materials, marketing and development plans, price lists,
pricing policies, business plans, information relating to customers and/or suppliers’ identities,
characteristics and agreements, financial information and projections and Employee files.
Confidential Information also includes any information described above which the Company obtains
from another party and which the Company treats and/or has an obligation to treat as confidential
or designates as Confidential Information, whether or not owned or developed by the Company. (The
term “Company,” as used in this Section 8, means not only athenahealth, Inc., but also any company,
partnership or entity which, directly or indirectly, controls, is controlled by or is under common
control with athenahealth, Inc..)

          (b) Both during the Employment Period and at all times thereafter, all Confidential
Information which Employee may now possess or access, may obtain during or after the Employment
Period, or may create prior to the end of the Employment Period will be held confidential by
Employee, and Employee will not (nor will Employee assist any other person to do so), directly or
indirectly, (i) reveal, report, publish or disclose such Confidential Information to any person,
firm, corporation, association or other entity for any reason or purpose whatsoever (other than in
the course of carrying out Employee’s duties hereunder or as expressly authorized by the Company),
(ii) render any services

-5-

 

to any person, firm, corporation, association or other entity to whom any
such Confidential Information, in whole or in part, has been disclosed or is threatened to be
disclosed by or at the instance of Employee, or (iii) use such Confidential Information except for
the benefit of the Company and in the course of Employee’s employment with the Company. The
foregoing will not apply to the extent Employee is required to disclose any Confidential
Information by applicable law or legal process so long as Employee promptly notifies the Company of
such pending disclosure and consults with the Company prior to such disclosure concerning the
advisability of seeking a protective order or other means of preserving the confidentiality of the
Confidential Information.

          (c) Any Inventions (as defined below) in whole or in part conceived, made or reduced to
practice by Employee (either solely or in conjunction with others) during or after the Employment
Period that are made through the use of any of the Confidential Information or any of the Company’s
equipment, facilities, supplies, trade secrets or time, or that relate to the Company’s business or
the Company’s actual or demonstrably anticipated research and development, or that result from any
work performed by Employee for the Company will belong exclusively to the Company and will be
deemed part of the Confidential Information for purposes of this Agreement, whether or not fixed in
a tangible medium of expression. The term “Inventions,” as used herein, means any ideas, designs,
concepts, techniques, inventions and discoveries, whether or not patentable or protectable by
copyright and whether or not reduced to practice, including, but not limited to, devices,
processes, drawings, works of authorship, computer programs, software, source codes, object codes,
interfaces and networks (and all components of the foregoing), methods and formulas together with
any improvements thereon or thereto, derivative works therefrom and know-how related thereto. The
provisions of this section are not meant to apply to those inventions (1) that Employee creates
without the use of any Confidential Information of the Company and/or without the use of any of the
Company’s resources, equipment, facilities, supplies, trades secrets or time, (2) that do not
relate to the Company’s business and/or the Company’s actual or demonstrably anticipated business,
research or development, (3) that do not result from any Company work assigned to or performed by
Employee or any other employee of the Company, and (4) that do not result from any work performed
by Employee during the hours Employee is scheduled to work for the Company or during the hours
Employee is working for the Company.

               (i) Without limiting the foregoing, any such Inventions will be deemed to be “works made for
hire” and the Company will be deemed to be the owner thereof, provided that in the event and to the
extent such works are determined not to constitute “works made for hire” as a matter of law,
Employee hereby irrevocably assigns and transfers to the Company all right, title and interest in
and to any such Inventions, including but not limited to all

-6-

 

related patents, copyrights and mask
works and all applications therefor and filings and notification with respect thereto.

               (ii) Employee will keep and maintain adequate and current written records (in the form of
notes, sketches, drawings or such other form(s) as may be specified by the Company) of all
Inventions made by Employee during the Employment Period or thereafter (including but not limited
to information relating to all Inventions which belong exclusively to the Company pursuant to the
provisions of this Section 8(c)), which records will be available at all times to the Company and
will remain the sole property of the Company. In the event that (A) any Invention is made,
conceived of or reduced to practice by Employee, either solely or in conjunction with others,
during the Employment Period, or (B) any Invention is made, conceived of or reduced to practice by
Employee after the Employment Period which belongs exclusively to the Company pursuant to the
provisions of this Section 8(c), Employee will promptly give notice and fully disclose in writing
such Invention to the Chairman of the Board and the Board of Directors of the Company.

               (iii) Employee will assist the Company (at the Company’s expense), either during or subsequent
to the Employment Period, to obtain and enforce for the Company’s benefit, patents, copyrights, and
mask work protection in any country for any and all Inventions made by Employee, in whole or in
part, the rights to which belong to or have been assigned to the Company pursuant to the provisions
of Section 8(c) hereof. Employee agrees to execute all applications, assignments, instruments and
papers and perform all acts as the Company or its counsel may deem necessary or desirable to obtain
any patents, copyrights or mask work protection in such Inventions and otherwise to protect the
interests of the Company therein. In the event the Company is unable to secure Employee’s
signature on any document necessary to apply for, prosecute, obtain, or enforce any patent,
copyright, or other right or protection relating to any Invention, whether due to mental or
physical incapacity or any other cause, Employee hereby irrevocably designates and appoints the
Company and each of its duly authorized officers and agents as Employee’s agents and
attorney-in-fact, to act for and in Employee’s behalf and stead to execute and file any such
document and to do all other lawfully permitted acts to further the prosecution, issuance, and
enforcement of patents, copyrights, or other right or protections with the same force and effect as
if executed and delivered by Employee.

          (d) All memoranda, notes, lists, records and other documents (and all copies thereof)
constituting Confidential Information (including information relating to all Inventions which
belong exclusively to the Company pursuant to the provisions of Section 8(c) above) made or
compiled by Employee or made available to Employee during or after the Employment Period shall be
the Company’s property, shall be kept confidential in accordance with the

-7-

 

provisions of this
Section 8 and shall be delivered to the Company at any time upon request and upon the termination
of Employee’s employment.

          (e) To the extent, if any, that Employee possesses or has knowledge of information that is
proprietary to a third party or that is subject to confidentiality restrictions properly placed
upon it by a third party that would prevent Company from having access to such information
(collectively “Third Party Information”), Employee shall not disclose such information to Company
or to any Company personnel nor shall Employee use such information in the conduct of Employee’s
employment hereunder. Employee’s duties hereunder expressly exclude use or disclosure of such
information. Company expressly disclaims any request or requirement that Employee disclose or use
Third Party Information with in connection with employment hereunder; and, if Employee encounters
such request or requirement, Employee will not make such disclosure or use but shall instead
promptly report such request or requirement to the Company’s acting compliance officer.

          (f) To the extent that Employee has been employed or retained by any third party in the past
whereby Employee has come into possession of Third Party Information, Employee warrants and
represents that Employee’s duties for Company as they have been described by Company in negotiation
of this Agreement are not substantially similar to those duties that Employee undertook for any
such third party such that any Third Party Information would naturally, necessarily or inevitably
be used or disclosed by Employee in performing her duties for the Company.

     9. Covenant Against Competition.

     Employee covenants and agrees that:

          (a) During the Non-Compete Period (as hereinafter defined), Employee shall not, in any
Geographic Area (as hereinafter defined): (i) engage in any business competitive with the Company
Business (as hereinafter defined); (ii) render any services in any capacity to any person or entity
engaged in any business competitive with the Company Business; or (iii) acquire an interest in any
person or entity engaged in any business competitive with the Company Business as a partner,
shareholder, director, officer, Employee, principal, manager, member, agent, trustee, consultant or
in any other relationship or capacity, provided, however, Employee may own, directly or indirectly,
solely as a passive investment, securities of any such entity which are traded on any national
securities exchange if Employee (A) is not a controlling person of, or a member of a group which
controls, such entity, and (B) does not, directly or indirectly, own 1% or more of any class of
securities of such entity.

-8-

 

          (b) During the Non-Compete Period, Employee shall not, without the prior written consent of
the Company, directly or indirectly, on behalf of himself or any other person or entity, solicit or
encourage any Employee of the Company or any of its Affiliates to leave the employment of the
Company or any of its Affiliates, or hire any Employee who has left the employment of the Company or any of
its Affiliates within one year of the termination of such Employee’s employment with the Company or
any of its Affiliates.

          (c) During the Non-Compete Period, Employee shall not, in any Geographic Area, directly or
indirectly (i) solicit or encourage any customer or client of the Company to engage the services
competitive with the Company Business of Employee or any person or entity (other than the Company)
in which Employee is a partner, shareholder, director, officer, employee, principal, member,
manager, agent, trustee, consultant or engaged in any other relationship or capacity, or (ii)
accept orders or business that is competitive with the Company Business from, or agree to provide
services competitive with the Company Business to, any customer or client of the Company, on behalf
of Employee or any person or entity (other than the Company) in which Employee is a partner,
shareholder, director, officer, employee, principal, member, manager, agent, trustee, consultant or
engaged in any other relationship or capacity.

          (d) If any provision of Sections 8 or 9 is held to be unenforceable, it is the intention of
the parties that the court making such determination shall modify such provision, so that the
provision shall be enforceable to the greatest extent permitted under the law, and that such
provision shall then be applicable in such modified form.

          (e) As used herein:

               (i) “Affiliate” shall mean any entity directly or indirectly controlling, controlled by, or
under common control with the Company and any entity in which the Company is a general partner,
member, manager or holder of greater than a 10% common equity, partnership or membership interest.

               (ii) “Company Business” shall mean the business of providing, contracting for or arranging for
provision of clinical record management, software or software functionality that is in whole or any
part integrated with, combined with or consolidated with services by the same or an affiliated
entity that involve, in whole or in any part, outsourcing or subcontracting of all or any portion
of the office or facility or enterprise workflow, business process, billing or revenue cycle tasks
of hospitals, clinics, physicians or other providers or practitioners of health care. An entity
will be deemed affiliated with another if: (a) it directly or indirectly is a parent, subsidiary,
joint venturer, or partner of the other; (b) if it directly or indirectly owns any interest in, is
owned in any part by or shares common ownership in

-9-

 

any part with the other; or, (c) if it hold
itself out as providing a joint, coordinated or integrated service, item or combination of service
and item with the other.

               (iii) “Geographic Area” shall mean the United States and Canada.

               (iv) “Non-Compete Period” shall mean the period during which Employee is employed by the
Company and an additional period that is the longer of: (a) one month following the termination of
Employee’s employment with the Company for each one month that Employee has been employed by the
Company, to a maximum period of one year following termination of Employee’s employment or (b) the
number of months base compensation, rounded up to the nearest month, provided as severance payment
under this Agreement, to a maximum period of one year following termination.

     10. Enforcement by Injunction.

     Employee acknowledges and agrees that the Company will be irreparably damaged if Employee
fails to comply with the provisions of Sections 8 or 9. Accordingly, the Company shall be entitled
to (i) an injunction or any other appropriate decree of specific performance (without the necessity
of posting any bond or other security in connection therewith) in case of any breach or threatened
breach of Employee’s covenants under Sections 8 or 9, (ii) damages in an amount equal to all
compensation, profits, monies, accruals, increments or other benefits derived or received by
Employee (or any associated party deriving such benefits, including but not limited to any future
employer of Employee) as a result of any such breach of Employee’s covenants under Sections 8 or 9,
and (iii) indemnification against any other losses, damages, costs and expenses, including actual
attorneys’ fees and court costs, incurred by the Company in obtaining any damages and/or injunctive
relief. Such remedies shall not be exclusive and shall be in addition to any other remedy, at law
or in equity, which the Company may have for any breach or threatened breach of Sections 8 or 9 by
Employee.

     11. Notices.

     Any and all notices or other communications required or permitted to be given under any of the
provisions of this Agreement shall be in writing and shall be deemed to have been duly given when
personally delivered or mailed by first class registered mail, return receipt requested, or by
commercial courier or delivery service, by facsimile or by receipted e-mail, addressed to the
parties at the addresses set forth below their signatures hereto (or at such

-10-

 

other address as any
party may specify by notice to all other parties given as aforesaid).

     12. Arbitration.

     Any dispute or controversy arising under this Agreement or concerning Employee’s employment
with the Company (including, without limitation, any controversy as to the arbitrability of any
dispute), including but not limited to any claims arising out of Title VII of the Civil Rights Act
of 1964, the Age Discrimination in Employment Act, the Americans with Disabilities Act, and/or
Massachusetts General Laws Chapter 151B, shall be settled exclusively by arbitration to be held in
Boston, Massachusetts, before a single arbitrator in accordance with the rules of the American
Arbitration Association then in effect relating to the arbitration of employment disputes,
provided, however, that any claims arising out of Sections 8, 9 and/or 10 of this Agreement may be
resolved either through arbitration or through the court system. Judgment may be entered on the
arbitrator’s award in any court having jurisdiction, and the parties consent to the jurisdiction of
the Massachusetts courts for that purpose.

     13. Miscellaneous.

          (a) This writing constitutes the entire agreement of the parties with respect to the subject
matter hereof and may not be modified, amended or terminated except by a written agreement signed
by all parties hereto, provided however that compensation levels may be adjusted by assent of the
parties, which assent of Company shall be in writing and signed on behalf of Company stating the
adjusted level and which assent of Employee will be established by acceptance by Employee of
compensation at such adjusted level.

          (b) No waiver of any breach or default hereunder shall be considered valid unless in writing
signed by all parties hereto, and no such waiver shall be deemed a waiver of any subsequent breach
or default of a similar nature.

          (c) If any provisions of this Agreement shall be held unenforceable, such unenforceability
shall attach only to such provisions and shall not render unenforceable any other severable
provisions of this Agreement, and this Agreement shall be carried out as if any such unenforceable
provisions were not contained herein, unless the unenforceability of such provisions substantially
impairs the benefits of the remaining portions of this Agreement.

          (d) This Agreement may be executed in two or more counterparts, each of which shall be deemed
one original.

-11-

 

          (e) This Agreement shall be deemed to be a contract under the laws of the Commonwealth of
Massachusetts and for all purposes shall be construed and enforced in accordance with the internal
laws of said Commonwealth.

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first above written.

	 	 	 	 	 	 	 
	Nancy G. Brown

	 	athenahealth, Inc.	 	 
	 
	 	 	 	 	 	 
	/s/ Nancy G. Brown
 

	 	 	 	 	 	 
	Employee signature
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Address:

	 	By:
	 	/s/ Jonathan Bush	 	 
	 

	 	 	 	Name: Jonathan Bush	 	 
	 

	 	 	 	Title: CEO	 	 
	 

	 	 	 	Address: One Moody Street,

	 	 
	 

	 	 	 	
                  Waltham, MA 02453	 	 

-12-THIRD LOAN MODIFICATION AGREEMENT

This Third Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of April 30, 2008, 2008, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts  02462 (“Bank”) and AXS-ONE INC., a Delaware corporation with its chief executive office located at 301 Route 17 North, Rutherford, New Jersey 07070 (“Borrower”).

1. DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and obligations which may be owing by Borrower to Bank, Borrower is indebted to Bank pursuant to a loan arrangement dated as of July 18, 2007, evidenced by, among other documents, a certain Second Amended and Restated Loan and Security Agreement dated as of July 18, 2007, between Borrower and Bank, as amended by a certain First Loan Modification Agreement dated as of November 12, 2007, and as further amended by a certain Second Loan Modification Agreement dated as of March 18, 2008 (as amended, the “Loan Agreement”). Capitalized terms used but not otherwise defined herein shall have the same meaning as in the Loan Agreement.

2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by the Collateral as described in the Loan Agreement and the Intellectual Property Collateral as described in a certain Intellectual Property Security Agreement dated as of October 31, 2006 (the “IP Security Agreement”) (together with any other collateral security granted to Bank, the  “Security Documents”).

Hereinafter, the Security Documents, together with all other documents evidencing or securing the Obligations shall be referred to as the “Existing Loan Documents”.

3. DESCRIPTION OF CHANGE IN TERMS.

	
                         
 	
                        A.
 	
                        Modifications to Loan Agreement.
 

	
                         
 	
                        1
 	
                        The Loan Agreement shall be amended by deleting the following appearing as Section 6.7 thereof:
 

“6.7 Financial Covenants. 

(a) Borrower shall have quarterly net losses of not more than (a) Four Million Dollars ($4,000,000.00) for the quarter ending June 30, 2007, and (b) Two Million Eight Hundred Thousand Dollars ($2,800,000.00) for the quarter ending September 30, 2007.

(b) Borrower shall have net losses of not more than (i) Four Million Six Hundred Fifty Thousand Dollars ($4,650,000.00) for the three-month period ending October 31, 2007, (ii) Four Million Seven Hundred Fifty Thousand Dollars ($4,750,000.00) for the three-month period ending November 30, 2007, (iii) Four Million One Hundred Thousand Dollars ($4,100,000.00) for the three-month period ending December 31, 2007, (iv) Four Million Three Hundred Thousand Dollars ($4,300,000.00) for the three-month period ending January 31, 2008, (v) Three Million Eight Hundred Thousand Dollars ($3,800,000.00) for the three-month period ending February 29, 2008, (vi) Two Million Eight Hundred Thousand Dollars ($2,800,000.00) for the three-month period ending March 31, 2008, (vii) Two Million Five Hundred Thousand

 

 

Dollars ($2,500,000.00) for the three-month periods ending April 30, 2008, May 31, 2008, June 30, 2008, July 31, 2008 and August 31, 2008, (viii) One Million Three Hundred Fifty Thousand Dollars ($1,350,000.00) for the three-month periods ending September 30, 2008, October 31, 2008 and November 30, 2008, and (ix) One Million Dollars ($1,000,000.00) for the three-month periods ending December 31, 2008, January 31, 2009, February 28, 2009 and March 31, 2009.

(c) Borrower shall provide evidence to Bank, as of the last day of each quarter, that that Borrower had license revenue during such quarter of at least (i) One Million Two Hundred Thousand Dollars ($1,200,000.00) during the quarter ended December 31, 2007, (ii) One Million Eight Hundred Fifty Thousand Dollars ($1,850,000.00) during the quarter ending March 31, 2008, (iii) Two Million One Hundred Twenty-Five Thousand Dollars ($2,125,000.00) during the quarter ending June 30, 2008, (iv) Two Million Five Hundred Fifty Thousand Dollars ($2,550,000.00) during the quarter ending September 30, 2008, (v) Two Million Eight Hundred Dollars ($2,800,000.00) during the quarter ending December 31, 2008, and (vi) Two Million Five Hundred Fifty Thousand Dollars ($2,550,000.00) during the quarter ending March 31, 2009.”

and inserting in lieu thereof the following:

“6.7 Financial Covenants. 

(a) EBITDA. Borrower shall have EBITDA of at least: (i) ($1,550,000.00) for the three-month period ended March 31, 2008; (ii) ($1,450,000.00) for the three-month period ending April 30, 2008; (iii) ($950,000.00) for the three-month period ending May 31, 2008; (iv) ($550,000.00) for the three-month period ending June 30, 2008; (v) ($165,000.00) for the three-month period ending July 31, 2008; (vi) ($55,000.00) for the three-month period ending August 31, 2008; and (vii) $1.00 for the three-month period ending September 30, 2008 and for the three-month period ending on the last day of each subsequent month.

(b) Liquidity. Borrower shall have Liquidity at all times, to be tested as of the last day of each month commencing with the month ended March 31, 2008, of at least $1,250,000; provided, however, Borrower shall have Liquidity of at least (i) $865,000 with respect to the month ending May 31, 2008, (ii) $500,000 with respect to the month ending August 31, 2008, and (iii) $800,000 with respect to the month ending November 30, 2008.

(c) Equity Event. Borrower shall provide evidence to Bank on or prior to July 31, 2008 of the occurrence of the Equity Event.”

	
                         
 	
                        2
 	
                        The Loan Agreement shall be amended by inserting the following new definitions appearing alphabetically in Section 13.1 thereof:
 

“ “2008 Closing Date” is April 30, 2008.”

“ “Availability” means (a) eighty percent (80.0%) of Borrower’s Eligible Accounts (net of any offsets related to each specific Account Debtor, including, without limitation, Deferred Revenue and maintenance) which are not Financed Receivables, minus (b) the outstanding principal amount of the Advances.”

 

“ “EBITDA” means (a) earnings before interest, taxes, depreciation and amortization in accordance with GAAP, plus (b) non-cash compensation expenses.”

“ “Equity Event” is the receipt by Borrower, after the 2008 Closing Date, of proceeds of equity or Subordinated Debt, in form and substance acceptable to Bank in Bank’s sole and absolute discretion, resulting in unrestricted net cash proceeds to Borrower of at least Five Hundred Thousand Dollars ($500,000.00).”

“ “Liquidity” is the sum of (a) Borrower’s unrestricted and unencumbered cash or cash equivalents as set forth on its balance sheet, plus (b) Availability.”

	
                         
 	
                        3
 	
                        The Loan Agreement is hereby amended by deleting the Compliance Certificate attached as Exhibit B thereto and inserting in lieu thereof the Compliance Certificate attached as Schedule 1 hereto.
 

	
                         
 	
                        B.
 	
                        Waiver. Bank hereby waives Borrower’s existing default under the Loan Agreement by virtue of Borrower’s failure to comply with the financial covenant set forth in Section 6.7(c) (relative to Borrower’s revenue) (as required prior to this Loan Modification Agreement) as of the quarter ended March 31, 2008. Bank’s waiver of Borrower’s compliance of said affirmative covenant shall apply only to the foregoing specific period.
 

4. FEES. Borrower shall pay to Bank a modification fee equal to Three Thousand Five Hundred Dollars ($3,500.00) which fee shall be due on the date hereof and shall be deemed fully earned as of the date hereof. Borrower shall also reimburse Bank for all legal fees and expenses incurred in connection with this amendment to the Existing Loan Documents.

5. RATIFICATION OF IP SECURITY AGREEMENT. Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and conditions of the IP Security Agreement and acknowledges, confirms and agrees that the IP Security Agreement contains an accurate and complete listing of all Intellectual Property Collateral as defined therein.

6. RATIFICATION OF PERFECTION CERTIFICATE. Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in a certain Perfection Certificate dated as of July 18, 2007 between Borrower and Bank, and acknowledges, confirms and agrees the disclosures and information Borrower provided to Bank in the Perfection Certificate have not changed, as of the date hereof.

7. CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever necessary to reflect the changes described above.

8. RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms all terms and conditions of all security or other collateral granted to the Bank, and confirms that the indebtedness secured thereby includes, without limitation, the Obligations.

9. NO DEFENSES OF BORROWER. Borrower hereby acknowledges and agrees that Borrower has no offsets, defenses, claims, or counterclaims against Bank with respect to the Obligations, or otherwise, and that if Borrower now has, or ever did have, any offsets, defenses, claims, or counterclaims against Bank, whether known or unknown, at law or in equity, all of them are hereby expressly WAIVED and Borrower hereby RELEASES Bank from any liability thereunder.

 

10. CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Obligations, Bank is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Loan Documents. Except as expressly modified pursuant to this Loan Modification Agreement, the terms of the Existing Loan Documents remain unchanged and in full force and effect. Bank’s agreement to modifications to the existing Obligations pursuant to this  Loan Modification Agreement in no way shall obligate Bank to make any future modifications to the Obligations. Nothing in this Loan Modification Agreement shall constitute a satisfaction of the Obligations. It is the intention of Bank and Borrower to retain as liable parties all makers of Existing Loan Documents, unless the party is expressly
released by Bank in writing. No maker will be released by virtue of this Loan Modification Agreement.

11.COUNTERSIGNATURE. This Loan Modification Agreement shall become effective only when it shall have been executed by Borrower and Bank.

[The remainder of this page is intentionally left blank]

 

This Loan Modification Agreement is executed as a sealed instrument under the laws of the Commonwealth of Massachusetts as of the date first written above.

 

	
                        BORROWER:
 	
                         
 	
                        BANK:
 
	
                        AXS-ONE INC.
 	
                         
 	
                        SILICON VALLEY BANK
 
	
                         
 	
                         
 	
                         
 
	
                        By: 
 	
                        /s/ Joseph P. Dwyer
 	
                         
 	
                        By: 
 	
                        /s/ Christine Egitto
 
	
                        Name: 
 	
                        Joseph P. Dwyer
 	
                         
 	
                        Name: 
 	
                        Christine Egitto
 
	
                        Title: 
 	
                        CFO
 	
                         
 	
                        Title: 
 	
                        Vice President
 

 

 

 

Schedule 1

EXHIBIT B

 

SPECIALTY FINANCE DIVISION

Compliance Certificate

I, an authorized officer of AXS-ONE INC. (“Borrower”) certify under the Second Amended and Restated Loan and Security Agreement (the “Agreement”) between Borrower and Silicon Valley Bank (“Bank”) as follows (all capitalized terms used herein shall have the meaning set forth in the Agreement):

Borrower represents and warrants for each Financed Receivable:

Each Financed Receivable is an Eligible Account.

Borrower is the owner with legal right to sell, transfer, assign and encumber such Financed Receivable;

The correct amount is on the Invoice Transmittal and is not disputed;

Except with respect to Deferred Revenue to the extent that it is not offset in accordance with the definition of Advance Rate, payment is not contingent on any obligation or contract and Borrower has fulfilled all its obligations as of the Advance Request and Invoice Transmittal date;

Each Financed Receivable is based on an actual sale and delivery of goods and/or services rendered, is due to Borrower,  is not past due or in default, has not been previously sold, assigned, transferred, or pledged and is free of any liens, security interests and encumbrances other than Permitted Liens;

There are no defenses, offsets, counterclaims or agreements for which the Account Debtor may claim any deduction or discount;

It reasonably believes no Account Debtor is insolvent or subject to any Insolvency Proceedings; 

It has not filed or had filed against it Insolvency Proceedings and does not anticipate any filing;

Bank has the right to endorse and/ or require Borrower to endorse all payments received on Financed Receivables and all proceeds of Collateral.

No representation, warranty or other statement of Borrower in any certificate or written statement given to Bank contains any untrue statement of a material fact or omits to state a material fact necessary to make the statement contained in the certificates or statement not misleading.

Additionally, Borrower represents and warrants as follows:

Borrower and each domestic Subsidiary is duly existing and in good standing in its state of formation and qualified and licensed to do business in, and in good standing in, any state in which the conduct of its business or its ownership of property requires that it be qualified except where the failure to do so could not reasonably be expected to cause a Material Adverse Change. The execution, delivery and performance of the Loan Documents have been duly authorized, and do not conflict with Borrower’s organizational documents, nor constitute an event of default under any material agreement by which Borrower is bound. Borrower is not in default under any agreement to which or by which it is bound in which the default could reasonably be expected to cause a Material Adverse Change.

 

 

Borrower has good title to the Collateral, free of Liens except Permitted Liens. All inventory is in all material respects of good and marketable quality, free from material defects. 

Borrower is not an “investment company” or a company “controlled” by an “investment company” under the Investment Company Act. Borrower is not engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower has complied in all material respects with the Federal Fair Labor Standards Act. Borrower has not violated any laws, ordinances or rules, the violation of which could reasonably be expected to cause a Material Adverse Change. None of Borrower’s or any Subsidiary’s properties or assets has been used by Borrower or any Subsidiary or, to the best of Borrower’s knowledge, by previous Persons, in disposing, producing, storing, treating, or transporting any hazardous substance other than legally. Borrower and each Subsidiary has timely filed all required
tax returns and paid, or made adequate provision to pay, all material taxes, except those being contested in good faith with adequate reserves under GAAP. Borrower and each Subsidiary has obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all government authorities that are necessary to continue its business as currently conducted except where the failure to obtain or make such consents, declarations, notices or filings would not reasonably be expected to cause a Material Adverse Change.

Borrower is in compliance with the financial covenants set forth in Section 6.7 of the Agreement.

All representations and warranties in the Agreement are true and correct in all material respects on this date, and Borrower represents that there is no existing Event of Default. 

Financial Covenants

 

	
                         
 	
                         
 	
                        Required
 	
                         
 	
                        Actual
 	
                         
 	
                        Compliance
 
	
                        Three-Month EBITDA (monthly)
 	
                         
 	
                        $
 	
                         
 	
                        *
 	
                        $
 	
                         
 	
                         
 	
      Yes  No
 
									

*    As set forth in Section 6.7(a) of the Agreement.

 

	
                         
 	
                         
 	
                        Required
 	
                         
 	
                        Actual
 	
                         
 	
                        Compliance
 
	
                        Liquidity (monthly)
 	
                         
 	
                        $
 	
                         
 	
                        *
 	
                        $
 	
                         
 	
                         
 	
      Yes  No
 
									

*    As set forth in Section 6.7(b) of the Agreement.

 

	
                         
 	
                         
 	
                        Required
 	
                         
 	
                        Actual
 	
                         
 	
                        Compliance
 
	
                        Equity Event (by July 31, 2008)
 	
                         
 	
                        $
 	
                        500,000
 	
                         
 	
                        $
 	
                         
 	
                         
 	
      Yes  No
 
									

 

	
                        Sincerely,  
 	
                         
 	
                         
 	
                         
 
	 	 	 	 
	
                         

 	
                         
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                         
 	
                         
 
	
                        Signature
 	
                         
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                         
 	
                         
 
	
                        Title
 	
                         
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                         
 	
                         
 
	
                        Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]